Building companies, accelerating development.
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.
Investor Login
Sign in to our secure investor area to receive personalized updates and information. Login now »
Recent Additions
- NeurAxon Announces Closing of Convertible Debenture Financing
- WALTHAM, MA. December 29, 2009 - NeurAxon, Inc., a development-stage pharmaceutical company that is designing and developing next-generation pain therapeutics... Read more
- Inverness Medical Innovations Enters Into Distribution Agreement with Epocal Inc.
- WALTHAM, Mass., Jan. 5 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take... Read more
